Skip to main content

The questions in the IRB application (section A.4.A; #s 4 and 5) relating to Investigational New Drug (IND) applications have been expanded and clarified.  As a reminder, the IND Exemption Checklist is available as a paper form at our website, forms.  Also, if you have questions regarding IND requirements or process, please call Amy Franklin, at TraCS Institute: 919-843-9514.

Comments are closed.